Novo Nordisk shares jump 8% after Wegovy sales beat expectations

• Novo Nordisk's Wegovy Sales Beat Expectations

  Business - The Wall Street Journal - 2 hours ago

• Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says

  Business - CNBC - 6 days ago

• The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research

  Top stories - CBS News - 2 days ago

• Barclays shares hit nine-year high after third quarter profit jumps 23%, beating expectations

  Business - CNBC - October 24

• Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies

  Business - CNBC - October 23

• Amazon shares jump 6% after earnings beat

  Business - CNBC - 4 days ago

• Snap shares jump after results come in better than expected

  Business - MarketWatch - October 30

• Netflix rose 11% after third-quarter earnings beat

  Business - CNBC - October 18

More from CNBC

• 10-year Treasury yield leaps above 4.40% as Trump nears election victory

  Business - CNBC - 17 minutes ago

• Trump Media shares surge 50% as Trump nears election win

  Business - CNBC - 1 hour ago

• Tesla jumps 12% as Trump-backer Musk seen benefiting from White House win

  Business - CNBC - 1 hour ago

• Super Micro shares plunge 17% after company says no timetable for annual results, issues weak guidance

  Business - CNBC - 11 hours ago

• Solar stocks tumble on fears Trump will hamper clean energy progress, repeal IRA

  Business - CNBC - 1 hour ago